posted by Phill Allen
October, 13th, 2014
Company News Pharmaceutical Industry News
Hospira has initiated a recall of one lot of Vancomycin Hydrochloride for Injection due to a storage “glitch” during shipment.
The supply chain error may have exposed the product to temperature fluctuations during transit to a customer leading to “uncontrolled storage”.
Whilst the product was further distributed by the customer, the Lake Forest, IL-based company assures that there have been no adverse events or complaints reported for the affected lot.
It also says that there is a lack of information to substantiate whether the effect of uncontrolled temperatures on vancomycin would degrade the product.
The recall action is being investigated purely “out of an abundance of caution”.
Read the recall notice
Hospira, Storage, Vancomycin Hydrochloride,
An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.